idarubicin
Selected indexed studies
- Idarubicin. (Tumori, 2002) [PMID:11989932]
- Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study. (Blood, 2011) [PMID:20693429]
- Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial. (Radiology, 2025) [PMID:40326873]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Idarubicin. (2002) pubmed
- Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study. (2011) pubmed
- Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial. (2025) pubmed
- Idarubicin: a second-generation anthracycline. (1991) pubmed
- Idarubicin. (1990) pubmed
- Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies. (1990) pubmed
- Clinical pharmacokinetics of idarubicin. (1993) pubmed
- Is Idarubicin the Future of TACE? (2019) pubmed
- Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies. (1986) pubmed
- Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. (1991) pubmed